Clinical Trial Update: Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated two oral doses of DMI-5207 in adults with diabetic macular edema and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• DMI-5207 (DMI-5207)

Snippet

Sponsor: Unity Health Toronto | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED